Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring

January 10, 2022 updated by: Bloom Technologies

The purpose of this study is to support the development of a new generation of the Bloomlife sensor, enabling continuous monitoring of foetal wellbeing.

Data is collected in four Phases, with different experimental setups. Recordings with investigational and reference devices are performed on the subjects, at different gestational ages.

The collected data is used for developing algorithms for the extraction of parameters descriptive of foetal wellbeing.

Clinical information related to subjects' pregnancy and foetal health is also collected.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

231

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Genk, Limburg, Belgium, 3600
        • Ziekenhuis Oost-Limburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant
  • Gestational age of at least 20 weeks
  • Singleton pregnancy
  • Willingness to participate in the study

Exclusion Criteria:

  • Multiple pregnancy
  • Implanted pacemaker or any other implanted electrical device
  • History of allergies to silicone-based adhesives

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Phase I
Data collections are performed with TMSi Porti system and CTG (reference)
Data collections
EXPERIMENTAL: Phases II-III-IV
Data collections are performed with the Bloomlife sensor and CTG (reference)
Data collections

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy and reliability in the detection of foetal heart rate
Time Frame: Throughout the subject's participation in the study, from inclusion until delivery
Foetal heart rate is extracted from the collected electrophysiological data and compared to the reference
Throughout the subject's participation in the study, from inclusion until delivery
Accuracy and reliability in the detection of foetal movements
Time Frame: Throughout the subject's participation in the study, from inclusion until delivery
Foetal movements are detected from the collected sensor data and compared to the reference
Throughout the subject's participation in the study, from inclusion until delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 5, 2018

Primary Completion (ACTUAL)

June 24, 2021

Study Completion (ACTUAL)

July 1, 2021

Study Registration Dates

First Submitted

May 28, 2019

First Submitted That Met QC Criteria

May 28, 2019

First Posted (ACTUAL)

May 31, 2019

Study Record Updates

Last Update Posted (ACTUAL)

January 25, 2022

Last Update Submitted That Met QC Criteria

January 10, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • BEATLE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Foetal Wellbeing

3
Subscribe